选刊必看:内分泌期刊Top20排名,还有投稿经验可取经!

2022-09-06 网络 网络

近1年内分泌学与代谢期刊排名发生了哪些变化,又有哪些期刊挺进了前20,让我们一起来看看吧!

近1年内分泌学与代谢期刊排名发生了哪些变化,又有哪些期刊挺进了前20,让我们一起来看看吧!

内分泌代谢领域顶流top20期刊
点击刊名查看详情

TOP 1 Nature Reviews Endocrinology 点击查看该期刊投稿经验  
TOP 2 Lancet Diabetes & Endocrinology 点击查看该期刊投稿经验  
TOP 3 Cell Metabolism 点击查看该期刊投稿经验  
TOP 4 ENDOCRINE REVIEWS 点击查看该期刊投稿经验  
TOP 5 Nature Metabolism 点击查看该期刊投稿经验  
TOP 6 DIABETES CARE 点击查看该期刊投稿经验  
TOP 7 METABOLISM-CLINICAL AND EXPERIMENTAL 点击查看该期刊投稿经验  
TOP 8 JOURNAL OF PINEAL RESEARCH 点击查看该期刊投稿经验  
TOP 9 Obesity Reviews 点击查看该期刊投稿经验  
TOP 10 TRENDS IN ENDOCRINOLOGY AND METABOLISM 点击查看该期刊投稿经验  
TOP 11 DIABETOLOGIA 点击查看该期刊投稿经验  
TOP 12 DIABETES 点击查看该期刊投稿经验  
TOP 13 REVIEWS IN ENDOCRINE & METABOLIC DISORDERS 点击查看该期刊投稿经验  
TOP 14 Obesity 点击查看该期刊投稿经验  
TOP 15 Cardiovascular Diabetology 点击查看该期刊投稿经验  
TOP 16 Biology of Sex Differences 点击查看该期刊投稿经验  
TOP 17 Molecular Metabolism 点击查看该期刊投稿经验  
TOP 18 FRONTIERS IN NEUROENDOCRINOLOGY 点击查看该期刊投稿经验  
TOP 19 DIABETES & METABOLISM 点击查看该期刊投稿经验  
TOP 20 DIABETES RESEARCH AND CLINICAL PRACTICE 点击查看该期刊投稿经验  

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2054734, encodeId=b2be2054e34c6, content=<a href='/topic/show?id=43f91e650d5' target=_blank style='color:#2F92EE;'>#TOP20#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17650, encryptionId=43f91e650d5, topicName=TOP20)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77b32500129, createdName=12498aa2m62(暂无昵称), createdTime=Thu Aug 03 14:35:59 CST 2023, time=2023-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682744, encodeId=e2fb1682e4405, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Wed May 24 11:35:59 CST 2023, time=2023-05-24, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2054734, encodeId=b2be2054e34c6, content=<a href='/topic/show?id=43f91e650d5' target=_blank style='color:#2F92EE;'>#TOP20#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17650, encryptionId=43f91e650d5, topicName=TOP20)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77b32500129, createdName=12498aa2m62(暂无昵称), createdTime=Thu Aug 03 14:35:59 CST 2023, time=2023-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682744, encodeId=e2fb1682e4405, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Wed May 24 11:35:59 CST 2023, time=2023-05-24, status=1, ipAttribution=)]
    2023-05-24 gwc392